February 2, 2022 admin

Daxor Corporation Commences Trading on The NASDAQ Capital Market

Management to Ring the Nasdaq Stock Market Opening Bell on February 4, 2022

Oak Ridge, TN – February 2, 2022 — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces it commenced trading on the NASDAQ Capital Markets as of today, February 2, 2022 and will visit the Nasdaq MarketSite in Times Square on Friday, February 4, 2022. In honor of the occasion, Michael Feldschuh, CEO & President will ring the Opening Bell.

“We are thrilled to commence trading on the NASDAQ Capital Markets today and believe that this milestone enables Daxor to better position the company to capitalize on Nasdaq’s long tradition of listing category-defining medical technology companies. This aligns well with Daxor’s innovative blood volume technology portfolio,” commented Michael Feldschuh, CEO and President of Daxor. “This move will improve the visibility of our stock, enhance trading liquidity in our shares, and provide us with greater exposure to institutional investors.”

Where:
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

When:
Friday, February 4, 2022 – 9:15 a.m. to 9:30 a.m. ET

Daxor Media Contact:
Linda Dyson
516-222-2560
Linda@coreir.com

Nasdaq MarketSite Media Contact:
Peter Gau
(201) 388-9682
Peter.gau@nasdaq.com

Feed Information:
Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0
DVBS QPSK